MET and adenocarcinoma: Biopsy confirmed adenocarcinoma (thyroid transcription factor-1 (TTF-1) +, Programmed Death-Ligand 1 (PD-L1) >80%), and next-generation sequencing revealed a MET exon 14 skipping mutation.